A clinical trial listing update for mazdutide was recorded on September 4, 2026. The study, titled "Efficacy of Mazdutide on Fatty Pancreas," is registered under identifier NCT07803705 on ClinicalTrials.gov.
The trial's current status is listed as not yet recruiting. Its phase is designated as NA, meaning no clinical trial phase has been assigned to this study at this time.
Mazdutide remains classified as an unapproved compound under research investigation. No results, outcomes, or efficacy data have been posted for this study as of this listing update.
This entry reflects only the registration status of the trial and does not indicate that participant enrollment has begun. The trial's purpose, as indicated by its title, concerns the study of mazdutide in relation to fatty pancreas, but no methodology, endpoints, or findings are included in this update.
Interested parties may continue to monitor the official ClinicalTrials.gov listing for changes in recruitment status, phase designation, or posted results as the study progresses. For more background on this compound, readers can refer to the mazdutide overview page.